Hematology Analyzers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Hematology Analyzers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Hematology Analyzers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Hematology Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hematology Analyzers consist of analytical laboratory equipment that is used to perform tests related to blood and blood components. These analyzers are also used to identify and determine morphology of blood and blood-forming cells such as white blood cells, lymphocytes, monocytes, neutrophils, eosinophils, and basophils.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hematology Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hematology Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hematology Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Hematology Analyzers Overview
4 Products under Development
4.1 Hematology Analyzers - Pipeline Products by Stage of Development
4.2 Hematology Analyzers - Pipeline Products by Segment
4.3 Hematology Analyzers - Pipeline Products by Territory
4.4 Hematology Analyzers - Pipeline Products by Regulatory Path
4.5 Hematology Analyzers - Pipeline Products by Estimated Approval Date
4.6 Hematology Analyzers - Ongoing Clinical Trials
5 Hematology Analyzers - Pipeline Products under Development by Companies
5.1 Hematology Analyzers Companies - Pipeline Products by Stage of Development
5.2 Hematology Analyzers – Companies Pipeline Products by Stage of Development
6 Hematology Analyzers Companies and Product Overview
6.1 Alentic Microscience Inc Company Overview
6.1.1 Alentic Microscience Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 Analyticon Biotechnologies AG Company Overview
6.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
6.3 Antigon SA Company Overview
6.3.1 Antigon SA Pipeline Products & Ongoing Clinical Trials Overview
6.4 Apollo Medical Devices LLC Company Overview
6.4.1 Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
6.5 Ativa Medical Inc Company Overview
6.5.1 Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.6 Baebies Inc Company Overview
6.6.1 Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 Bio-AMD Inc Company Overview
6.7.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 Cellmic LLC Company Overview
6.8.1 Cellmic LLC Pipeline Products & Ongoing Clinical Trials Overview
6.9 Daxor Corp Company Overview
6.9.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
6.1 Diatron Medical Instruments Limited Company Overview
6.10.1 Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview
6.11 iFirst Medical Technologies LLC Company Overview
6.11.1 iFirst Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
6.12 Ionu Biosystems Company Overview
6.12.1 Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview
6.13 IRIS International Inc Company Overview
6.13.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
6.14 I-Sens Inc Company Overview
6.14.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview
6.15 Meridian Bioscience Inc Company Overview
6.15.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
6.16 MicroX Labs Inc Company Overview
6.16.1 MicroX Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
6.17 NGeneBio Co Ltd Company Overview
6.17.1 NGeneBio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.18 Quotient Ltd Company Overview
6.18.1 Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.19 Rutgers The State University of New Jersey Company Overview
6.19.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview
6.2 Siemens Healthcare Diagnostics Inc Company Overview
6.20.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.21 Sysmex Corp Company Overview
6.21.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
6.22 The University of British Columbia Company Overview
6.22.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
6.23 Trinity Biotech Plc Company Overview
6.23.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
7 Hematology Analyzers- Recent Developments
7.1 Nov 02, 2023: Haemonetics Announces Second Quarter Fiscal Year 2024
7.2 Oct 31, 2023: Samsung Electronics Reports Q3 2023 Results
7.3 Oct 27, 2023: Tokuyama Corp Announces Consolidated Financial Statements for the Second Quarter Fiscal 2023
7.4 Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7.5 Oct 11, 2023: CellaVision Invitation to Presentation for the Third Quarter 2023 on October 25, at 11:00 CEST
7.6 Oct 11, 2023: Eurobio Scientific : Results for the First Half of 2023
7.7 Sep 11, 2023: Dirui Industrial Appoints Lin Maoliang as Non-Independent Directors
7.8 Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
7.9 Jul 27, 2023: Tokuyama Announces First Quarter Results of Fiscal 2023
7.1 Jul 12, 2023: T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results
7.11 Jul 10, 2023: Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2024 Results
7.12 Jul 06, 2023: Trinity Biotech Announces Q1 2023 Financial Results
7.13 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO
7.14 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
7.15 May 15, 2023: T2 Biosystems postpones reporting of first quarter 2023 financial results
7.16 May 11, 2023: Haemonetics announces fourth quarter fiscal year 2023 earnings
7.17 May 05, 2023: CellaVision: Bulletin from annual general meeting 2023
7.18 Apr 28, 2023: Biolidics Announces Annual General Meeting
7.19 Apr 25, 2023: Haemonetics sets date for publishing fourth quarter and fiscal year 2023 results: May 11, 2023
7.2 Apr 21, 2023: Invitation to presentation of the CellaVision report for the first quarter 2023 on May 4, at 11:00 CEST
7.21 Apr 05, 2023: Eurobio Scientific Announces 2022 Annual Results
7.22 Apr 03, 2023: Cellavision Notice Of Annual General Meeting
7.23 Mar 31, 2023: Biolidics Announces Appointment of Independent Director
7.24 Mar 28, 2023: EKF Diagnostics Holdings Announces its final results for the year ended 31 December 2022
7.25 Mar 13, 2023: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results
7.26 Mar 02, 2023: Daxor to Report Fiscal Year 2022 Financial Results on Wednesday, March 1, 2023 and Provide Corporate Update
7.27 Feb 27, 2023: Tokuyama Corp. Notice concerning Change of Representative Director
7.28 Feb 16, 2023: Samsung Electronics Announces 2022 Consolidated Financial Statements
7.29 Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
7.3 Feb 08, 2023: Eurobio Scientific formalises the appointment of Anne-Sophie Herelle as Group CFO
7.31 Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors
7.32 Feb 07, 2023: Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2023 Results; Updates Fiscal 2023 Guidance
7.33 Jan 31, 2023: Tokuyama Announces Summary of Consolidated Financial Statements for the Third Quarter Fiscal 2022
7.34 Jan 23, 2023: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results
7.35 Jan 16, 2023: Samsung hires ex-Yogiyo CEO to lead online sales as rivals axe jobs
7.36 Jan 13, 2023: Daxor Corporation to exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress
7.37 Jan 06, 2023: Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
7.38 Dec 30, 2022: Samsung Appoints Hubert H. Lee To Lead Its MX Design Team
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Hematology Analyzers - Pipeline Products by Stage of Development
Table 2: Hematology Analyzers - Pipeline Products by Segment
Table 3: Hematology Analyzers - Pipeline Products by Territory
Table 4: Hematology Analyzers - Pipeline Products by Regulatory Path
Table 5: Hematology Analyzers - Pipeline Products by Estimated Approval Date
Table 6: Hematology Analyzers - Ongoing Clinical Trials
Table 7: Hematology Analyzers Companies - Pipeline Products by Stage of Development
Table 8: Hematology Analyzers – Companies Pipeline Products by Stage of Development
Table 9: Alentic Microscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Prospector Point-of-Care Complete Blood Cell Counts Analyzer - Product Status
Table 11: Prospector Point-of-Care Complete Blood Cell Counts Analyzer - Product Description
Table 12: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Hemolyzer 5 - Product Status
Table 14: Hemolyzer 5 - Product Description
Table 15: Antigon SA Pipeline Products & Ongoing Clinical Trials Overview
Table 16: ISABO Device - Product Status
Table 17: ISABO Device - Product Description
Table 18: Apollo Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Portable Blood Analysis System - Product Status
Table 20: Portable Blood Analysis System - Product Description
Table 21: Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Ativa MicroLab System - Product Status
Table 23: Ativa MicroLab System - Product Description
Table 24: Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Anticoagulation Monitor - Product Status
Table 26: Anticoagulation Monitor - Product Description
Table 27: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Blood Coagulation Monitor - Product Status
Table 29: Blood Coagulation Monitor - Product Description
Table 30: Cellmic LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 31: LUCAS - Product Status
Table 32: LUCAS - Product Description
Table 33: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 34: BVA-100 - Acute Decompensated Heart Failure - Product Status
Table 35: BVA-100 - Acute Decompensated Heart Failure - Product Description
Table 36: BVA-100 - POTS - Product Status
Table 37: BVA-100 - POTS - Product Description
Table 38: BVA-100 Combat Casualty Care - Product Status
Table 39: BVA-100 Combat Casualty Care - Product Description
Table 40: Next Gen BVA-100 - Product Status
Table 41: Next Gen BVA-100 - Product Description
Table 42: Diatron Medical Instruments Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Abacus 380 - Product Status
Table 44: Abacus 380 - Product Description
Table 45: Diatron Aquila - Product Status
Table 46: Diatron Aquila - Product Description
Table 47: iFirst Medical Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 48: iFirst Analyzer - Product Status
Table 49: iFirst Analyzer - Product Description
Table 50: Ionu Biosystems Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Fluorescent Smart Phone Blood Analyzer - Product Status
Table 52: Fluorescent Smart Phone Blood Analyzer - Product Description
Table 53: IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 54: GEMS Hematology Analyzer - Product Status
Table 55: GEMS Hematology Analyzer - Product Description
Table 56: I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: i-Smart 30 - Mg - Product Status
Table 58: i-Smart 30 - Mg - Product Description
Table 59: Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Next Generation Pediatric Blood Chemistry Analyzer - Product Status
Table 61: Next Generation Pediatric Blood Chemistry Analyzer - Product Description
Table 62: MicroX Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Complete Blood Count Homecare Device - Cancer - Product Status
Table 64: Complete Blood Count Homecare Device - Cancer - Product Description
Table 65: Complete Blood Count Homecare Device - Flu - Product Status
Table 66: Complete Blood Count Homecare Device - Flu - Product Description
Table 67: Complete Blood Count Homecare Device - Infertility - Product Status
Table 68: Complete Blood Count Homecare Device - Infertility - Product Description
Table 69: NGeneBio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Easy HLA Analyzer - Product Status
Table 71: Easy HLA Analyzer - Product Description
Table 72: Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 73: MosaiQ - Product Status
Table 74: MosaiQ - Product Description
Table 75: Quotient Ltd - Ongoing Clinical Trials Overview
Table 76: MosaiQ - Clinical Internal Evaluation of MosaiQ for Diagnosis of Blood Transfusion Diseases
Table 77: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Automated Robotic Device - Blood Testing - Product Status
Table 79: Automated Robotic Device - Blood Testing - Product Description
Table 80: Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 81: ADCIA 2120 Hematology System - Product Status
Table 82: ADCIA 2120 Hematology System - Product Description
Table 83: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 84: Automated Hematology Analyzer XN-31 - Product Status
Table 85: Automated Hematology Analyzer XN-31 - Product Description
Table 86: Sysmex XQ-320 Automated Hematology Analyzer - Product Status
Table 87: Sysmex XQ-320 Automated Hematology Analyzer - Product Description
Table 88: The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Portable Hematology Analyzer - Product Status
Table 90: Portable Hematology Analyzer - Product Description
Table 91: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Premier Resolution System - Product Status
Table 93: Premier Resolution System - Product Description
Table 94: Glossary
2.2 List of Figures
Figure 1: Hematology Analyzers - Pipeline Products by Stage of Development
Figure 2: Hematology Analyzers - Pipeline Products by Segment
Figure 3: Hematology Analyzers - Pipeline Products by Territory
Figure 4: Hematology Analyzers - Pipeline Products by Regulatory Path
Figure 5: Hematology Analyzers - Pipeline Products by Estimated Approval Date
Figure 6: Hematology Analyzers - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings